Floatz logo

Therapeutic Asset Ratings

1,055 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
[18f]f-resca-rt4
Head And Neck Cancer
RenJi HospitalP2/3CCC (52)
[18F]F-RESCA-T4
Urinary Bladder Carcinoma
RenJi HospitalP2/3CCC (52)
[18F]F-RESCA-T4
Cholangiocarcinoma
RenJi HospitalP2/3CCC (52)
[18F]F-RESCA-T4
Head And Neck Cancer
RenJi HospitalP2/3CCC (52)
[68ga]ga-nota-rt4
Urinary Bladder Carcinoma
RenJi HospitalP2/3CCC (52)
[68ga]ga-nota-rt4
Cholangiocarcinoma
RenJi HospitalP2/3CCC (52)
[68ga]ga-nota-rt4
Head And Neck Cancer
RenJi HospitalP2/3CCC (52)
[68ga]ga-nota-t4
Urinary Bladder Carcinoma
RenJi HospitalP2/3CCC (52)
[68ga]ga-nota-t4
Cholangiocarcinoma
RenJi HospitalP2/3CCC (52)
[68ga]ga-nota-t4
Head And Neck Cancer
RenJi HospitalP2/3CCC (52)
Acetyl-L-Carnitine
Amyotrophic Lateral Sclerosis
Mario Negri Institute for Pharmacological ResearchP2/3CCC (52)
Adderall Xr
Multiple Sclerosis
Sarah MorrowP2/3CCC (52)
Allopurinol
Depressive Disorder
Tanta UniversityP2/3CCC (52)
Allostim®
Hepatocellular Carcinoma
Mirror Biologics, Inc.P2/3CCC (52)
Avastinib
Acute Myeloid Leukemia
Ruijin HospitalP2/3CCC (52)
Avtozma
B-Cell Acute Lymphoblastic Leukemia
Merck Sharp & Dohme LLCP2/3CCC (52)
Bl-M11D1
Acute Myeloid Leukemia
Sichuan Baili Pharmaceutical Co., Ltd.P2/3CCC (52)
bp102
Colorectal Cancer
West China HospitalP2/3CCC (52)
Budigalimab
Non-Small Cell Lung Carcinoma
AbbVieP2/3CCC (52)
Cidabenamine
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineP2/3CCC (52)
Cobimetinib
Colorectal Neoplasm
Cancer Research UKP2/3CCC (52)
Cobimetinib
Glioma
Cancer Research UKP2/3CCC (52)
Cobimetinib
Ovarian Neoplasm
Cancer Research UKP2/3CCC (52)
Dabigatran
Cirrhosis Of Liver
Institute of Liver and Biliary Sciences, IndiaP2/3CCC (52)
Dabrafenib
Colorectal Neoplasm
Cancer Research UKP2/3CCC (52)
Showing 851 to 875 of 1,055 assets
PreviousPage 35 of 43Next